drugset / Trial / NCT00955513

Evaluate the Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel Applied Twice or Three Times Daily in Patients With Acute Ankle Sprain

NCT00955513

Phase 3 Completed 242 enrolled Novartis
RandomizedParallel-groupTriple-blindTreatment

Summary

The main purpose of this trial is to compare the efficacy and safety of diclofenac diethylamine 2.32% gel applied twice (b.i.d) or three times a day (t.i.d.) with placebo in the treatment of acute ankle sprains (distortions).

Timeline

Start
2009-07
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac diethylamine Unknown 2.32 %

Indications

No indication recorded.